Husin, Farhadz S.
HRN: 21-58-08 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2022
AMPICILLIN 250MG (VIAL)
07/04/2022
07/10/2022
IV
150mg
Q12
PSNB Secondary To Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes